a lona hit this weekend. come on, there is a long race hit this weekend. come on, there is a long race to hit this weekend. come on, there is a long race to go. hit this weekend. come on, there is a long race to go, right? hit this weekend. come on, there is a long race to go, right? still- a long race to go, right? still opportunities. sis a long race to go, right? still opportunities. a long race to go, right? still opportunities. as i said, i know what s going opportunities. as i said, i know what s going to opportunities. as i said, i know what s going to happen. - opportunities. as i said, i know what s going to happen. do - opportunities. as i said, i know what s going to happen. do the opportunities. as i said, i know- what s going to happen. do the best i can tomorrow. ethan hayter could become the first home winner of the tour of britain in five years later today. belgium s yves lompart won the penultimate stage into edinburgh. hayter finished sixth to retain his
AI Drug Development Investments Accelerated in 2020
News provided by
Share this article
Share this article
MILTON KEYNES, England, Dec. 30, 2020 /PRNewswire/ The market for AI in Drug Development had a record year in 2020 with $2.9B new funding and a total funding in the industry reaching $9.2B. But while the annual investment value is reaching new heights, the number of funding rounds has continued its downfall. Emersion Insights has analysed the investment landscape and categorised the industry into Information Engines, Drug Design and Clinical Trials.
AI in Drug Development - Completed Funding Rounds per Year (source: Emersion Insights)
Most Funded Vendors in 2020